This is the logo of the provider
5 June 2026

Impact  of Once-Weekly Injectable Semaglutide Versus Placebo on Fatty Liver Index Scores in People with Overweight/Obesity: A Post Hoc Analysis (STEP 1)

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Obesity
Congress poster
GLP-1 RA
Semaglutide
RWE HEOR